Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Mar-Apr;15(2):143-151.
doi: 10.21873/cgp.20072.

LINE-1 ORF1 Protein Is Up-regulated by Reactive Oxygen Species and Associated with Bladder Urothelial Carcinoma Progression

Patcharawalai Whongsiri  1 , Chaowat Pimratana  2 , Udomsak Wijitsettakul  2 , Depicha Jindatip  3 , Anapat Sanpavat  4 , Wolfgang A Schulz  5 , Michèle J Hoffmann  5 , Wolfgang Goering  6 , Chanchai Boonla  7
Affiliations

LINE-1 ORF1 Protein Is Up-regulated by Reactive Oxygen Species and Associated with Bladder Urothelial Carcinoma Progression

Patcharawalai Whongsiri et al. Cancer Genomics Proteomics. 2018 Mar-Apr.

Abstract

Background/aim: Reactivation of long interspersed nuclear element-1 (LINE-1) and oxidative stress are suggested to have oncogenic potential to drive tumorigenesis and cancer progression. We previously demonstrated that reactive oxygen species (ROS) caused hypomethylation of LINE-1 elements in bladder cancer cells. In this study, we investigated the expression of LINE-1-encoded protein (ORF1p) and oxidative stress marker 4-hydroxynonenal (4-HNE) in human bladder cancer tissues, as well as induction of ORF1p expression by ROS in bladder cancer cell lines.

Materials and methods: Thirty-six cancerous and 15 non-cancerous adjacent tissues were immunohistochemically stained for ORF1p and 4-HNE. ORF1p expression and cell migration were determined in bladder cancer cells exposed to H2O2 Results: ORF1p and 4-HNE expression was higher in cancerous than non-cancerous tissues. Elevated ORF1p expression was associated with increased 4-HNE expression and with advanced tumors. H2O2 provoked oxidative stress and up-regulated ORF1p expression in VM-CUB-1 compared to the untreated control, and to a lesser degree in TCCSUP. H2O2 exposure enhanced cell migration in UM-UC-3, TCCSUP and VM-CUB-1.

Conclusion: Elevated ORF1p expression is associated with tumor progression. ROS experimentally induce ORF1p expression and promote migration in bladder cancer cells.

Keywords: 4-HNE; LINE-1; ORF1p; bladder cancer; cancer progression; immunohistochemistry; oxidative stress.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Representative micrographs of ORF1p and 4-HNE expression in bladder cancer tissues. ORF1p was negative or expressed at very low levels in non-cancerous bladder tissues (A and C). In contrast, expression of ORF1p in bladder cancer tissues was remarkably increased (B and D). Similar to ORF1p, 4-HNE expression was elevated in bladder cancer tissues (F), but it was obviously low in non-cancerous bladder tissues (E). Magnifications: ×100 (A and B), ×400 (C-F).
Figure 2
Figure 2. Levels of ORF1p and 4-HNE expression compared between cancerous and non-cancerous bladder tissues, and correlation of ORF1p and 4-HNE expression in bladder cancer tissues. Both ORF1p expression (A) and 4-HNE (B) levels were significantly higher in bladder cancer tissues than in non-cancerous bladder tissues. In paired cancerous and non-cancerous tissue samples, significantly higher levels of ORF1p (C) and 4-HNE (D) expression were observed in cancerous areas compared to adjacent non-cancerous regions. ORF1p expression was positively correlated with 4-HNE expression in bladder cancer tissues (E).
Figure 3
Figure 3. Association of ORF1p expression with bladder tumor progression. ORF1p expression in muscle-invasive bladder tumors was significantly higher than that in papillary/superficial (non muscle-invasive) tumors (A). Likewise, expression of ORF1p in high-grade tumors was significantly higher than low-grade tumors (B). Left: representative immunostainings; right: quantitative evaluation.
Figure 4
Figure 4. Induction of ORF1p expression by ROS in bladder cancer cell lines. In VM-CUB-1 cells (A), exposure to H2O2 (30 μM for 72 h) caused a significant increase in ORF1p expression compared to untreated controls, and this increment was effectively normalized by co-treatment with antioxidants (for 72 h), TA (300 μM) and SAM (100 μM). In TCCSUP cells (B), ORF1p expression was slightly increased after H2O2 exposure without reaching statistical significance. Co-treatment with SAM significantly caused reduction of ORF1p expression in H2O2-treated cells.
Figure 5
Figure 5. Scratch assay showing ROS-induced cell migration in bladder cancer cell lines, UM-UC-3, TCCSUP and VM-CUB-1. UM-UC-3 and TCCSUP were treated with H2O2 for 72 h, but VM-CUB-1 for 6 h. All H2O2-treated cells migrated faster to fill the gaps than the untreated control cells. Co-treatment with TA reduced the migration capability of the H2O2-treated cells.
See this image and copyright information in PMC

References

    1. Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W, Funke R, Gage D, Harris K, Heaford A, Howland J, Kann L, Lehoczky J, LeVine R, McEwan P, McKernan K, Meldrim J, Mesirov JP, Miranda C, Morris W, Naylor J, Raymond C, Rosetti M, Santos R, Sheridan A, Sougnez C, Stange-Thomann Y, Stojanovic N, Subramanian A, Wyman D, Rogers J, Sulston J, Ainscough R, Beck S, Bentley D, Burton J, Clee C, Carter N, Coulson A, Deadman R, Deloukas P, Dunham A, Dunham I, Durbin R, French L, Grafham D, Gregory S, Hubbard T, Humphray S, Hunt A, Jones M, Lloyd C, McMurray A, Matthews L, Mercer S, Milne S, Mullikin JC, Mungall A, Plumb R, Ross M, Shownkeen R, Sims S, Waterston RH, Wilson RK, Hillier LW, McPherson JD, Marra MA, Mardis ER, Fulton LA, Chinwalla AT, Pepin KH, Gish WR, Chissoe SL, Wendl MC, Delehaunty KD, Miner TL, Delehaunty A, Kramer JB, Cook LL, Fulton RS, Johnson DL, Minx PJ, Clifton SW, Hawkins T, Branscomb E, Predki P, Richardson P, Wenning S, Slezak T, Doggett N, Cheng JF, Olsen A, Lucas S, Elkin C, Uberbacher E, Frazier M, Gibbs RA, Muzny DM, Scherer SE, Bouck JB, Sodergren EJ, Worley KC, Rives CM, Gorrell JH, Metzker ML, Naylor SL, Kucherlapati RS, Nelson DL, Weinstock GM, Sakaki Y, Fujiyama A, Hattori M, Yada T, Toyoda A, Itoh T, Kawagoe C, Watanabe H, Totoki Y, Taylor T, Weissenbach J, Heilig R, Saurin W, Artiguenave F, Brottier P, Bruls T, Pelletier E, Robert C, Wincker P, Smith DR, Doucette-Stamm L, Rubenfield M, Weinstock K, Lee HM, Dubois J, Rosenthal A, Platzer M, Nyakatura G, Taudien S, Rump A, Yang H, Yu J, Wang J, Huang G, Gu J, Hood L, Rowen L, Madan A, Qin S, Davis RW, Federspiel NA, Abola AP, Proctor MJ, Myers RM, Schmutz J, Dickson M, Grimwood J, Cox DR, Olson MV, Kaul R, Raymond C, Shimizu N, Kawasaki K, Minoshima S, Evans GA, Athanasiou M, Schultz R, Roe BA, Chen F, Pan H, Ramser J, Lehrach H, Reinhardt R, McCombie WR, de la Bastide M, Dedhia N, Blocker H, Hornischer K, Nordsiek G, Agarwala R, Aravind L, Bailey JA, Bateman A, Batzoglou S, Birney E, Bork P, Brown DG, Burge CB, Cerutti L, Chen HC, Church D, Clamp M, Copley RR, Doerks T, Eddy SR, Eichler EE, Furey TS, Galagan J, Gilbert JG, Harmon C, Hayashizaki Y, Haussler D, Hermjakob H, Hokamp K, Jang W, Johnson LS, Jones TA, Kasif S, Kaspryzk A, Kennedy S, Kent WJ, Kitts P, Koonin EV, Korf I, Kulp D, Lancet D, Lowe TM, McLysaght A, Mikkelsen T, Moran JV, Mulder N, Pollara VJ, Ponting CP, Schuler G, Schultz J, Slater G, Smit AF, Stupka E, Szustakowki J, Thierry-Mieg D, Thierry-Mieg J, Wagner L, Wallis J, Wheeler R, Williams A, Wolf YI, Wolfe KH, Yang SP, Yeh RF, Collins F, Guyer MS, Peterson J, Felsenfeld A, Wetterstrand KA, Patrinos A, Morgan MJ, de Jong P, Catanese JJ, Osoegawa K, Shizuya H, Choi S, Chen YJ, Szustakowki J, International Human Genome Sequencing C Initial sequencing and analysis of the human genome. Nature. 2001;409:860–921. - PubMed
    1. Brouha B, Schustak J, Badge RM, Lutz-Prigge S, Farley AH, Moran JV, Kazazian HH Jr. Hot L1s account for the bulk of retrotransposition in the human population. Proc Natl Acad Sci USA. 2003;100:5280–5285. - PMC - PubMed
    1. Beck CR, Collier P, Macfarlane C, Malig M, Kidd JM, Eichler EE, Badge RM, Moran JV. LINE-1 retrotransposition activity in human genomes. Cell. 2010;141:1159–1170. - PMC - PubMed
    1. Doucet-O’Hare TT, Rodic N, Sharma R, Darbari I, Abril G, Choi JA, Young Ahn J, Cheng Y, Anders RA, Burns KH, Meltzer SJ, Kazazian HH Jr. LINE-1 expression and retrotransposition in Barrett’s esophagus and esophageal carcinoma. Proc Natl Acad Sci USA. 2015;112:E4894–4900. - PMC - PubMed
    1. Rodic N, Burns KH. Long interspersed element-1 (LINE-1): passenger or driver in human neoplasms. PLoS Genet. 2013;9:e1003402. - PMC - PubMed

LinkOut - more resources